FDA approves Tivicay pd for youngest HIV patients New treatment option expands paediatric HIV care access Read More
Connected trials Clinical trials are becoming increasingly complex. In a 2023 survey, 70% of investigative site... Read More
Koala trial doses first patient with novel KMA‑targeting CAR‑T Australian teams advance first‑in‑human multiple myeloma therapy Read More
Heparegenix wins orphan drug status for darizmetinib Designation supports development for post‑hepatectomy liver failure Read More
IMAVVY approved as first targeted therapy for wAIHA New treatment reduces pathogenic IgG while preserving B‑cell function Read More